Bluebird Bio Presents Positive Early Results of Gene Therapy LentiGlobin for Sickle Cell Disease – Sickle Cell Anemia News
Sickle Cell Anemia News |
Bluebird Bio Presents Positive Early Results of Gene Therapy LentiGlobin for Sickle Cell Disease
Sickle Cell Anemia News Participants with severe SCD were split into three groups – A, B and C. Patients in group A received the treatment according to the trial's original protocol: After cells are collected from the bone marrow, they are transduced with the LentiGlobin … |
